Building a Texas-based center for neuroblastoma clinical research.
|
Baylor College of Medicine / Heidi Russell, MD |
Phase I/II Infrastructure Grants |
2006 |
Texas |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine / Stephen Gottschalk, M.D. |
Innovation Grants |
2014 |
Texas |
Mediators of Metastasis in Alveolar Rhabdomyosarcoma.
|
University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD |
Young Investigator Grants |
2006 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Adoptive immunotherapy using clinical-grade T cells.
|
University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD |
Innovation Grants |
2007 |
Texas |
Parallel sequencing to identify the causes of childhood cancer
|
Baylor College of Medicine / Sharon Plon |
Innovation Grants |
2008 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML |
Baylor College of Medicine / Michele Redell, M.D./Ph.D. |
Springboard Grants |
2014 |
Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |